Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00354042
NCT00354042
View on ClinicalTrials.gov
Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects
PHASE1
Completed
INTERVENTIONAL
Enrollment
24
Participants
Timeline
Start Date
August 31, 2004
Conditions
Asthma
Interventions
DRUG
GW597901X
Sponsors
Lead Sponsor
GlaxoSmithKline
All Listed Sponsors
lead
GlaxoSmithKline
INDUSTRY
NCT00354042 - Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects | Biotech Hunter | Biotech Hunter